Science study unveils Virtual Biotech, a multi-agent AI system for drug development
james_y_zou · x · 2026-09-25
A new study in Science presents Virtual Biotech, a multi-agent AI system designed to inform drug-development decisions. By combining diverse biomedical and clinical evidence on a unified platform, the system may help surface therapeutic opportunities that would otherwise be missed.
More from Research
- Theoretical Neuroscience podcast: how neuromorphic computing could speed up AI and cut energy use — neurovium · 2026-09-25
- Offloading Score, a new measure of AI over-reliance, earns NeurIPS 2026 Oral — Diyi_Yang · 2026-09-25
- AgenticGenTAMP: coding agents synthesize reusable robot TAMP policies across 28 envs — tomssilver · 2026-09-25
- Princeton-led work uses coding agents to synthesize reusable policies for generalized task and motion planning — tomssilver · 2026-09-25
- 98,000 simulated evaluations reveal robots making surprisingly clever physical reasoning — tomssilver · 2026-09-25
- RIKEN AIP team proposes practical Bayes-optimal fairness-accuracy tradeoff estimation with soft labels — RatnRajiv · 2026-09-25